Eisai Co., Ltd. (ESALF)
ESALF Stock Price Chart
Explore Eisai Co., Ltd. interactive price chart. Choose custom timeframes to analyze ESALF price movements and trends.
ESALF Company Profile
Discover essential business fundamentals and corporate details for Eisai Co., Ltd. (ESALF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
7 Apr 2011
Employees
11.07K
Website
https://www.eisai.co.jpCEO
Haruo Naito
Description
Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company also provides Lyrica for pain treatment; Dayvigo, an anti-insomnia drug for the treatment of adults with insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; and Halaven, an anticancer agent/microtubule dynamics inhibitor for the treatment of breast cancer and liposarcoma. In addition, it offers Pariet, a proton-pump inhibitor for the treatment of gastric and duodenal ulcers, reflux esophagitis, and eradication of Helicobacter pylori infections, etc.; Humira, a fully human anti-TNF-a monoclonal antibody for the treatment of autoimmune diseases, such as rheumatoid arthritis; and Chocola BB plus, a vitamin B2 preparation for rough skin and stomatitis, as well as various products, which include third-class OTC drugs, designated quasi-drugs, and food with nutrient function. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.
ESALF Financial Timeline
Browse a chronological timeline of Eisai Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 5 Feb 2026
Upcoming earnings on 5 Nov 2025
Revenue estimate is $200.22B.
Earnings released on 5 Aug 2025
EPS came in at $0.36 surpassing the estimated $0.27 by +32.50%, while revenue for the quarter reached $1.41B , beating expectations by +4.72%.
Dividend declared on 15 May 2025
A dividend of $0.55 per share was announced, adjusted to $0.55.
Dividend declared on 15 May 2025
A dividend of $0.55 per share was announced, adjusted to $0.55. The dividend will be paid on 1 Nov 2025.
Earnings released on 13 May 2025
EPS came in at $3.36 surpassing the estimated $0.12 by +2.64K%, while revenue for the quarter reached $1.25B , beating expectations by +9.07%.
Earnings released on 4 Feb 2025
EPS came in at $84.31 surpassing the estimated $0.26 by +32.33K%, while revenue for the quarter reached $1.37B , beating expectations by +13.41%.
Earnings released on 8 Nov 2024
EPS came in at $39.18 surpassing the estimated $32.09 by +22.09%, while revenue for the quarter reached $1.36B , beating expectations by +7.58%.
Earnings released on 2 Aug 2024
EPS came in at $36.95 surpassing the estimated $18.30 by +101.91%, while revenue for the quarter reached $1.18B , beating expectations by +4.63%.
Earnings released on 15 May 2024
EPS came in at $46.40 surpassing the estimated $35.18 by +31.89%, while revenue for the quarter reached $1.26B , beating expectations by +0.17%.
Dividend declared on 15 May 2024
A dividend of $0.53 per share was announced, adjusted to $0.53. The dividend was paid on 30 May 2025.
Dividend declared on 15 May 2024
A dividend of $0.56 per share was announced, adjusted to $0.55. The dividend was paid on 19 Nov 2024.
Earnings released on 6 Feb 2024
EPS came in at $20.82 surpassing the estimated $20.70 by +0.58%, while revenue for the quarter reached $1.27B , missing expectations by -1.81%.
Earnings released on 7 Nov 2023
EPS came in at $9.72 falling short of the estimated $28.50 by -65.89%, while revenue for the quarter reached $1.18B , beating expectations by +4.39%.
Earnings released on 2 Aug 2023
EPS came in at $70.92 surpassing the estimated $10.39 by +582.58%, while revenue for the quarter reached $1.36B , beating expectations by +7.78%.
Earnings released on 15 May 2023
EPS came in at $56.92 surpassing the estimated $0.61 by +9.29K%, while revenue for the quarter reached $1.50B , missing expectations by -5.14%.
Dividend declared on 15 May 2023
A dividend of $0.53 per share was announced, adjusted to $0.53. The dividend was paid on 29 May 2024.
Dividend declared on 15 May 2023
A dividend of $0.54 per share was announced, adjusted to $0.54. The dividend was paid on 17 Nov 2023.
Earnings released on 6 Feb 2023
EPS came in at $30.14 surpassing the estimated $0.23 by +13.18K%, while revenue for the quarter reached $1.45B , missing expectations by -4.28%.
Earnings released on 7 Nov 2022
EPS came in at $12.44 surpassing the estimated $0.19 by +6.55K%, while revenue for the quarter reached $1.21B , missing expectations by -2.36%.
Earnings released on 5 Aug 2022
EPS came in at $93.81 surpassing the estimated $40.12 by +133.82%, while revenue for the quarter reached $1.36B , beating expectations by +16.14%.
Earnings released on 13 May 2022
EPS came in at -$43.27 falling short of the estimated -$4.51 by -859.42%, while revenue for the quarter reached $1.56B , beating expectations by +4.56%.
Dividend declared on 13 May 2022
A dividend of $0.60 per share was announced, adjusted to $0.60. The dividend was paid on 29 May 2023.
Dividend declared on 13 May 2022
A dividend of $0.56 per share was announced, adjusted to $0.56. The dividend was paid on 18 Nov 2022.
Earnings released on 3 Feb 2022
EPS came in at $49.43 falling short of the estimated $67.25 by -26.50%, while revenue for the quarter reached $1.76B , beating expectations by +12.39%.
Earnings released on 1 Nov 2021
EPS came in at $14.04 , while revenue for the quarter reached $1.47B , missing expectations by -4.09%.
Earnings released on 4 Aug 2021
EPS came in at $147.07 surpassing the estimated $51.76 by +184.14%, while revenue for the quarter reached $1.79B .
Earnings released on 12 May 2021
EPS came in at -$10.64 surpassing the estimated -$20.00 by +46.80%, while revenue for the quarter reached $1.34B , missing expectations by -99.32%.
Dividend declared on 12 May 2021
A dividend of $0.66 per share was announced, adjusted to $0.65. The dividend was paid on 25 May 2022.
Dividend declared on 12 May 2021
A dividend of $0.72 per share was announced, adjusted to $0.72. The dividend was paid on 19 Nov 2021.
Earnings released on 3 Feb 2021
EPS came in at $67.58 , while revenue for the quarter reached $1.75B .
Earnings released on 5 Nov 2020
EPS came in at $4.78 , while revenue for the quarter reached $1.43B .
Dividend declared on 13 May 2020
A dividend of $0.73 per share was announced, adjusted to $0.73. The dividend was paid on 21 May 2021.
Dividend declared on 13 May 2020
A dividend of $0.76 per share was announced, adjusted to $0.76. The dividend was paid on 19 Nov 2020.
ESALF Stock Performance
Access detailed ESALF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.